Three Dimensional Virtual Reconstruction (3D) in Percutaneous Nephrolithotomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAdiyaman University

About this trial

The aim of our study is to investigate the effect of 3D imaging technique on the PCNL learning curve in specialist training.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with kidney stones larger than 2 cm and those with PCNL indication.

Disqualifiers

Patients with missing CT images, missing clinical information, or inaccessible

Trial design

Design model

Parallel

Treatments tested in this trial

  • 3D imaging technique on the PCNL

    Procedure/Surgery

    Establishing a percutaneous access route for the stone is the first and most important step in PCNL surgery. Choosing the perfect route, position and direction largely depends on surgical experience and the ability to understand renal/peri-renal anatomy. In general, a good CT scan of the abdomen and pelvis and an experienced surgeon are sufficient, but this requires significant time in the learning curve. The aim of our study is to investigate the effect of 3D imaging technique on the PCNL learning curve in specialist training.

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: 3D imaging technique on the PCNLExperimental treatment 1 intervention
Group B: standard PCNLNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Number of Participants with perioperative Bleeding.

Time frame
immediately after the intervention/procedure/surgery
2

Number of Participants with stone free

Time frame
1 month after the intervention/procedure/surgery
3

leng of the hospital stay

Time frame
immediately after the intervention/procedure/surgery

Secondary outcomes

1

Number of Participants with Complication

Time frame
immediately after the intervention/procedure/surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.